Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,334,142
in 2 filings, $1.3M under 10b5-1 plans

Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Fordyce Marshall −$1.3M PRESIDENT AND CEO sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2022-02-06 Young Joseph R SVP, Finance, Chief Acct Offcr Purchase +5,714 $7.00 $40K 22,679
2022-02-06 Grant Sean Chief Financial Officer Purchase +14,285 $7.00 $100K 49,933
2021-12-10 Hall Kimball Director Grant or award · Stock Option (right to buy) +19,850 19,850
2021-07-13 Grant Sean Chief Financial Officer Grant or award · Stock Option (right to buy) +180,000 180,000
2021-05-18 Sofinnova Venture Partners X, L.P. 10% owner Conversion +2,187,504 2,187,504
2021-05-18 Sofinnova Venture Partners X, L.P. 10% owner Purchase +727,272 $11.00 $8.0M 2,914,776
2021-05-18 Sofinnova Venture Partners X, L.P. 10% owner Conversion · Series C Preferred Stock −2,187,504 0
2021-05-18 Longitude Capital Partners IV, LLC 10% owner Conversion +2,187,504 2,187,504
2021-05-18 Longitude Capital Partners IV, LLC 10% owner Purchase +909,090 $11.00 $10.0M 3,096,594
2021-05-18 Longitude Capital Partners IV, LLC 10% owner Conversion · Series C Preferred Stock −2,187,504 0
2021-05-18 Katabi Maha Director Conversion +2,187,504 2,187,504
2021-05-18 Katabi Maha Director Purchase +727,272 $11.00 $8.0M 2,914,776
2021-05-18 Katabi Maha Director Conversion · Series C Preferred Stock −2,187,504 0
2021-05-18 SEIDENBERG BETH C Director Conversion +423,642 423,642
2021-05-18 SEIDENBERG BETH C Director Conversion +100,526 524,168
2021-05-18 SEIDENBERG BETH C Director Conversion +818,984 1,343,152
2021-05-18 SEIDENBERG BETH C Director Conversion · Series A Preferred Stock −423,642 0
2021-05-18 SEIDENBERG BETH C Director Conversion · Series B Preferred Stock −100,526 0
2021-05-18 SEIDENBERG BETH C Director Conversion · Series C Preferred Stock −818,984 0
2021-05-18 ENRIGHT PATRICK G Director Conversion +2,187,504 2,187,504

Page 28 of 30 · 581 trades